Unique Ingredient Identifier GGO4Y809LO is listed as a ingredient substance
| RN | 108-39-4 |
| EC | 203-577-9 |
| NCIT | C80603 |
| RXCUI | 1367170 |
| PUBCHEM | 342 |
| MF | C7H8O |
| INCHI KEY | RLSSMJSEOOYNOY-UHFFFAOYSA-N |
| SMILES | CC1=CC(O)=CC=C1 |
UNII GGO4Y809LO METACRESOL is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| IM - IV - SC | INJECTION | 0.1 % |
| IM - SC | INJECTION | 0.25 % |
| INTRADERMAL | INJECTION | 0.16 % |
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.3 % |
| INTRAVENOUS | INJECTION | 3 MG/1ML |
| INTRAVENOUS | SOLUTION, INJECTION | 3.15 MG/1ML |
| IV - SC | INJECTION, SOLUTION | 1.72 MG/1ML |
| IV(INFUSION) | INJECTION | 0.1 % |
| SUBCUTANEOUS | INJECTABLE | 0.32 % |
| SUBCUTANEOUS | INJECTION | 0.32 % |
| SUBCUTANEOUS | INJECTION, SOLUTION | 0.27 % |
| SUBCUTANEOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.3 % |
| SUBCUTANEOUS | SOLUTION | 0.083 % |
| SUBCUTANEOUS | SOLUTION, INJECTION | 0.27 % |
| SUBCUTANEOUS | SUSPENSION | 0.18 % |
| SUBCUTANEOUS | SUSPENSION, INJECTION | 0.22 % |